Neurol. praxi. 2012;13(5):265-269
Painful diabetic neuropathy - evidence-based therapy
- Neurologická klinika PKN, a.s., a FZS, Univerzita Pardubice
Painful diabetic neuropathy developes in 16 % of all diabetics and in 40–50 % of diabetics with previously diagnosed diabetic neuropathy.
Various medicaments are used in treatment of neuropatic pain in painful diabetic neuropathy: antidepressants, anticonvulsants,
opioids, topically administered drugs, other medicaments and non-pharmacological procedures. According to evidence of pain-relieving
effects in painful diabetic neuropathy there were evaluted more than 2000 citations, the titles and abstracts of which 79 were chosen,
that fulfilled all the criteria of evaluating panel (from AAN – American Academy of Neurology). The highest level of recommendation
(level A) reached pregabalin, then duloxetine (with respect to its adverse events, level B), then venlafaxine, tricyclic antidepressants,
gabapentin, opioids, capsaicin. The combination of drugs is successful (e.g. with opioids).
Keywords: neuropathic pain, diabetic neuropathy, antidepressants, anticovulsants, opioids, topical agents
Published: November 1, 2012 Show citation
References
- Ambler Z. Bolestivé diabetické neuropatie. Bolest 2009; 11(1): 9-14.
- Attal N, Cruccu G, Baron R, Naanpää M, Hansson P, Jensen TS, Nurmikko T. EFNS guidelines on pharmacological treatment of neuropathic pain: 2009 revision. Eur J Neurol 2010; 17(9): 1113-1123.
Go to original source... 
Go to PubMed... - Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanismus, and treatment. Lancet Neurology 2010; 9: 807-819. Go to original source... Go to PubMed...
- Bednařík J, Ambler Z, Opavský J, Keller O, Rokyta R, Mazanec R, Lejčko J, Kozák J, Suchý M, Pátá M, Kožený P. Klinický standard pro farmakoterapii neuropatické bolesti. Cesk Slov Neurol N 2012; 75/108(1): 93-101.
- Bril V, England J, Franklin GM, Bakonja M, Cohen J, Del Toro D, Feldman E, Iverson DJ, Perkins B, Russel JW, Zochodne D. Evidence-based guideline: treatment of painful diabetic neuropathy. Neurology 2011; 76: 1758-1765. Go to original source... Go to PubMed...
- Cruccu G. Treatment of painful neuropathy. Curr Opin Neurol 2007; 20: 531-535. Go to original source... Go to PubMed...
- Freeman RL. Painful peripheral neuropathy: diagnosis and assessment. Continuum 2009; 15(5): 13-29. Go to original source...
- Kaur S, Pandhi P, Dutta P. Painful diabetic neuropathy: an update. Annals of Neurosicences 2011; 18(4): 168-174. Go to original source... Go to PubMed...
- NICE Clinical guidelines 96. Neuropatic pain. The pharmacological management of neuropathic pain in adults in non-specialists settting. 2010: 1-155.
- Stern TA. Massachusetts General Hospital Handbook of General Hospital Psychiatry, 5th edition, Philadelpia, CV Mosby 2004: 314.
- Tanenberg RJ, Irving G, Risser RC, Ahl J, Robinson MJ, Skljarevski V, Malcolm SK. Duloxetine, pregabalin, and duloxetin plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison. Mayo Clin Proc 2011; 86(7): 615-626. Go to original source... Go to PubMed...
- Tesfaye S, Vileikyte L, Rayman G, Sindrup SH, Baconja M, Vinik AI, Boulton AJM. Painful diabetic peripheral neurpathy: consensus recommendations on diagnosis, assessment and managemetn. Diabetes Metab Res Rev 2011; 27: 629-638. Go to original source... Go to PubMed...
- Vadivelu N, Hines RL. Management of chronic pain in the elderly: focus on transdermal buprenorphine. Clin Interventions in Aging 2008; 3(3): 421-430. Go to original source... Go to PubMed...
- Ziegler D, Pritchett YL, Wand F, Desalah D, Robinson MJ, Hall JA, Chappell AS. Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain. Diabetes Care 2007; 30(3): 664-669. Go to original source... Go to PubMed...